authors
- Edelmann, J
- Tausch, E
- Landau, Dan Avi
- Robrecht, S
- Bahlo, J
- Fischer, K
- Fink, A M
- Bloehdorn, J
- Holzmann, K
- Böttcher, S
- Werner, L
- Kneba, M
- Gribben, J G
- Neuberg, D S
- Wu, C J
- Hallek, M
- Döhner, H
- Stilgenbauer, S
Frequent evolution of copy number alterations in CLL following first-line treatment with FC(R) is enriched with TP53 alterations: results from the CLL8 trial.
Article
Overview
publication date
- November 2, 2016
published in
- Leukemia Journal
Research
keywords
- DNA Copy Number Variations
- Leukemia, Lymphocytic, Chronic, B-Cell
- Rituximab
- Tumor Suppressor Protein p53
Identity
PubMed Central ID
- PMC5332302
Scopus Document Identifier
- 85000956475
Digital Object Identifier (DOI)
- 10.1038/leu.2016.317
PubMed ID
- 27909343
Additional Document Info
has global citation frequency
volume
- 31
issue
- 3